Frank Brown

Publications (4)0 Total impact

• Article: Comparison of azabicyclic esters and oxadiazoles as ligands for the muscarinic receptor

  Barry S. Orlek, Frank E. Blaney, Frank Brown, Michael S. G. Clark, Michael S. Hadley, John Hatcher, Graham J. Riley, Howard E. Rosenberg, Harry J. Wadsworth, Paul Wyman
  04/2002;
• Article: Design of [R-(Z)]-(+)-α-(Methoxyimino)-1-azabicyclo[2.2.2]octane-3-acetonitrile (SB 202026), a Functionally Selective Azabicyclic Muscarinic M1 Agonist Incorporating the N-Methoxy Imidoyl Nitrile Group as a Novel Ester Bioisostere

  Steven M. Bromidge, Frank Brown, Frederick Cassidy, Michael S. G. Clark, Steven Dabbs, Michael S. Hadley, Julie Hawkins, Julia M. Loudon, Christopher B. Naylor, Barry S. Orlek, Graham J. Riley
  [show abstract] [hide abstract]
  ABSTRACT: Loss of cholinergic function is believed to be implicated in the cognitive decline associated with senile dementia of the Alzheimer type (SDAT). The disease is characterized by progressive loss of muscarinic receptors located on nerve terminals while postsynaptic muscarinic M1 receptors appear to remain largely intact. Muscarinic agonists acting directly on postsynaptic receptors offer the prospect of countering the cholinergic deficit in SDAT. This study describes a novel series of azabicyclic muscarinic agonists, which incorporate an oxime ether or modified oxime ether group as an ester bioisostere. Modification of the oxime ether function by the introduction of electron withdrawing groups led to the finding that the (Z)-N-methoxy imidoyl nitrile group serves as a stable methyl ester bioisostere. This culminated in the discovery of the quinuclidinyl N-methoxy imidoyl nitrile R-(+)-(Z)-5g which is a functionally selective muscarinic M1 partial agonist currently in phase III clinical trials for the treatment of SDAT. The selective profile of R-(+)-(Z)-5g can be rationalized in terms of the relative affinity of the compound at muscarinic receptor subtypes, the degree of agonist efficacy, and brain penetrancy.
  12/1997;
• Article: A novel and selective class of azabicyclic muscarinic agonists incorporating an N-methoxy imidoyl halide or nitrile functionality

  Steven M. Bromidge, Frank Brown, Frederick Cassidy, Michael S.G. Clark, Steven Dabbs, Julie Hawkins, Julia M. Loudon, Barry S. Orlek, Graham J. Riley
  Bioorganic & Medicinal Chemistry Letters. 2(8):791-796.
• Article: 1,2,5,6-tetrahydropyridine oxime ethers incorporating electron withdrawing groups are potent and selective muscarinic agonists

  Steven M. Bromidge, Frank Brown, Frederick Cassidy, Michael S.G. Clark, Emma J. Collings, Steven Dabbs, Richard E. Faulkner, Julia M. Loudon, Barry S. Orlek, Graham J. Riley
  Bioorganic & Medicinal Chemistry Letters. 4(4):557-562.